Delivery Order SPE2DB20D2014-SPE2DB25FC84E
- Not listed
- The Defense Logistics Agency awarded a $5,279.79 delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Novolog 100 Unit/ML FlexPen 3ML insulin pens, with completion expected by September 11, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The product will be performed at the contractor's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $3,173.46 to AmerisourceBergen Drug Corp for Novolog 100 Unit/ML FlexPen 3ML insulin pens on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $8,073.48 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Novolog 100 Unit/ML FlexPen 3ML insulin pens. This is a firm fixed price contract with a completion date of September 18, 2025, and represents a non-competitive, non-set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed this work from its corporate office location. The delivery order serves as a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $5,262.89 on August 22, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $2,709.76 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Novolog 100 Unit/ML FlexPen 3ML insulin pens. This non-set-aside, competitively awarded contract carries a firm fixed price structure with an ultimate completion date of August 13, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $1,853.05 on August 7, 2025, for the supply of Novolog 100 Unit/mL Flexpen 3mL insulin pens. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 8, 2025. As a child order under a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $2,108.70. This competitively awarded, non-set-aside contract represents a firm fixed price delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $8,844.26 to AmerisourceBergen Drug Corp for the supply of Novolog 100 Unit/ML FlexPen 3ML insulin pens. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, awarded on August 21, 2025, without a set-aside designation. The award will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $4,011.10 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Novolog 100 Unit/ML FlexPen 3ML insulin pens, with an ultimate completion date of July 22, 2025. This non-set-aside competitive award was issued on July 21, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens, with a ceiling value of $1,022.69. This firm fixed-price delivery order represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through December 2026. The insulin pens are to be...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC84EDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,773.66 to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Novolog 100 Unit/mL FlexPen 3mL insulin pens. This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, represents a non-competitive set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order under its broader contractual relationship with DLA for medical supply chain support. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement running through December 2026 that enables comprehensive global pharmaceutical support for military healthcare programs. The contract vehicle supports the supply of a wide range of pharmaceutical products and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Novolog insulin delivery represents a critical medical commodity supporting diabetes management across federal military and veteran healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.8k | 8/26/25 |